Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

TETRACYCLINES FOR TUMOURS NOW?

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    TETRACYCLINES FOR TUMOURS NOW?. Inpharma Wkly. 215, 9–10 (1979). https://doi.org/10.1007/BF03302553

    Download citation